SPOTLIGHT: Calpers withholding votes from Lilly directors

California's public-employee pension fund will withhold its votes for three Eli Lilly directors up for re-election next month, citing a lagging stock price and poor corporate governance. Among the three is John Lechleiter (photo), scheduled to become chief executive next month. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.